Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis
Follow-up CTC assessments strongly predict OS independently from tumor subtype and treatment. New randomized trials to define the clinical utility of CTC monitoring for risk stratification and as an early response marker in metastatic breast cancer are urgently needed.
Authors
- Rafael López‐López (ORCID: https://orcid.org/0000-0003-1315-655X)
- François‐Clément Bidard (ORCID: https://orcid.org/0000-0001-5932-8949)
- Leon W.M.M. Terstappen (ORCID: https://orcid.org/0000-0001-5944-3787)
- Brigitte Rack (ORCID: https://orcid.org/0000-0002-7539-4839)
- Jean‐Yves Pierga (ORCID: https://orcid.org/0000-0002-2863-9995)
- Meredith M. Regan (ORCID: https://orcid.org/0000-0002-2428-6109)
- Daniele Generali (ORCID: https://orcid.org/0000-0003-2480-3855)
- Paola Gazzaniga (ORCID: https://orcid.org/0000-0002-2325-2273)
- Minetta C. Liu (ORCID: https://orcid.org/0000-0002-8206-5232)
- Markus Wallwiener (ORCID: https://orcid.org/0000-0002-4139-9340)
- José Á. García-Sáenz (ORCID: https://orcid.org/0000-0001-6880-0301)
- José Vidal-Martínez (ORCID: https://orcid.org/0000-0002-5986-7966)
- Massimo Cristofanilli (ORCID: https://orcid.org/0000-0002-4194-7175)
- Jeffrey B. Smerage (ORCID: https://orcid.org/0000-0001-9130-9342)
- Tracy C. Yab (ORCID: https://orcid.org/0000-0002-9116-8428)
- Elisabetta Munzone (ORCID: https://orcid.org/0000-0003-3371-3878)
- Thomas W. P. Friedl (ORCID: https://orcid.org/0000-0002-4773-8067)
- Luís Manso (ORCID: https://orcid.org/0000-0002-1683-550X)
- Catherine Alix‐Panabières (ORCID: https://orcid.org/0000-0002-6401-2903)
- Wolfgang Janni (ORCID: https://orcid.org/0000-0001-5911-2400)
- Stefan Sleijfer (ORCID: https://orcid.org/0000-0002-0446-9039)
- Klaus Pantel (ORCID: https://orcid.org/0000-0001-5736-2772)
- Evi Lianidou (ORCID: https://orcid.org/0000-0002-7796-5914)
- Kostandinos Sideras (ORCID: https://orcid.org/0000-0002-4698-2105)
- Lisa A. Carey (ORCID: https://orcid.org/0000-0003-2388-4649)
- William Jacot (ORCID: https://orcid.org/0000-0001-7834-061X)
- Lorenzo Gerratana (ORCID: https://orcid.org/0000-0002-8313-4834)
- Rafael Gisbert‐Criado (ORCID: https://orcid.org/0000-0003-4845-3706)
- Simon A. Joosse (ORCID: https://orcid.org/0000-0002-4296-5615)
- Michail Ignatiadis (ORCID: https://orcid.org/0000-0002-4493-3748)
- Daniel F. Hayes (ORCID: https://orcid.org/0000-0003-3620-7575)
- Mark Jesus M. Magbanua (ORCID: https://orcid.org/0000-0003-2113-3593)
- Zefei Jiang (ORCID: https://orcid.org/0000-0002-4295-0173)
- Luc Dirix (ORCID: https://orcid.org/0000-0002-6248-1677)
- Sabine Riethdorf (ORCID: https://orcid.org/0000-0003-0028-5643)
- Justin Stebbing (ORCID: https://orcid.org/0000-0002-1117-6947)
- William E. Barlow (ORCID: https://orcid.org/0000-0003-4651-2282)
- Tanja Fehm (ORCID: https://orcid.org/0000-0002-4926-0108)
- Volkmar Mueller (ORCID: https://orcid.org/0000-0003-4231-7906)
- Carlos Caldas (ORCID: https://orcid.org/0000-0003-3547-1489)
- Hope S. Rugo (ORCID: https://orcid.org/0000-0001-6710-4814)
- Karthik V. Giridhar (ORCID: https://orcid.org/0000-0003-4640-9197)
- Dimitriοs Mavroudis (ORCID: https://orcid.org/0000-0003-0587-1713)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Udine (IT)
- Université Libre de Bruxelles (BE)
- Mayo Clinic (US)
- University of Trieste (IT)
- University of Antwerp (BE)
- Inserm (FR)
- Universität Hamburg (DE)
- University of California, San Francisco (US)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- National and Kapodistrian University of Athens (GR)
- Université Paris Cité (FR)
- Cornell University (US)
- Heidelberg University (DE)
- University of Cambridge (GB)
- University of Michigan (US)
- Jacksonville College (US)
- Institut Jules Bordet (BE)
- Erasmus MC (NL)
- WinnMed (US)
- Chinese PLA General Hospital (CN)
- Hospital Clínico San Carlos (ES)
- Düsseldorf University Hospital (DE)
- Cancer Research UK Cambridge Center (GB)
- Centre Hospitalier Universitaire de Montpellier (FR)
- GZA Ziekenhuizen Campus Sint-Augustinus (BE)
- 307th Hospital of Chinese People’s Liberation Army (CN)
- Cancer Research And Biostatistics (US)
- Hospital Universitario 12 De Octubre (ES)
- University Medical Center Hamburg-Eppendorf (DE)
- Michigan United (US)
- Michigan Medicine (US)
- Dana-Farber Cancer Institute (US)
- Michigan Center for Translational Pathology (US)
- Hospital Arnau de Vilanova (ES)
- National Cancer Institute (UA)
- Natera (United States) (US)
- Mayo Clinic in Arizona (US)
- University Hospital of Heraklion (GR)
- Institut de Recherche en Cancérologie de Montpellier (FR)
- Mayo Clinic in Florida (US)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Erasmus MC Cancer Institute (NL)
- University Hospital in Halle (DE)
- University Hospital Ulm (DE)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- Weill Cornell Medicine (US)
- Institut Regional du Cancer de Montpellier (FR)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Heinrich Heine University Düsseldorf (DE)
- Anglia Ruskin University (GB)
- European Institute of Oncology (IT)
- Institut Curie (FR)
- Heidelberg University (US)
- Sapienza University of Rome (IT)
- University of Twente (NL)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-3108
- Citations
- 9
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 9.41
Funders
- Menarini Silicon Biosystems